Intangible Assets

12 Months Ended

Oct. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangible Assets

Goodwill

(In millions)	CooperVision			CooperSurgical			Total
Balance as of October 31, 2013	$	1,048.5		$	339.1		$	1,387.6
Net additions during the year ended October 31, 2014	857.1			25.5			882.6
Translation	(44.1		)	(5.2		)	(49.3		)
Balance as of October 31, 2014	$	1,861.5		$	359.4		$	2,220.9
Net (reductions) additions during the year ended October 31, 2015	(1.2		)	17.4			16.2
Translation	(32.7		)	(7.3		)	(40.0		)
Balance as of October 31, 2015	$	1,827.6		$	369.5		$	2,197.1

Of the October 31, 2015 goodwill balance, $93.5 million for CooperSurgical and $19.7 million for CooperVision is expected to be deductible for tax purposes.

Other Intangible Assets

	As of October 31, 2015				As of October 31, 2014
(In millions)	Gross Carrying Amount		Accumulated Amortization & Translation		Gross Carrying Amount		Accumulated Amortization & Translation		Weighted Average Amortization Period
									(In years)
Trademarks	$	23.7	$	4.4	$	21.3	$	2.9	13
Technology	318.9		114.7		326.6		93.8		11
Customer relationships	247.0		104.5		233.2		90.7		14
License and distribution rights and other	71.7		26.6		73.5		13.6		8
	661.3		$	250.2	654.6		$	201.0	12
Less accumulated amortization and translation	250.2				201.0
Other intangible assets, net	$	411.1			$	453.6

Included in Technology at October 31, 2015 is $39.5 million of acquired in-process research and development from Sauflon that is not amortized. See Note 2 for additional information on acquired intangible assets from Sauflon.

We estimate that amortization expense for our existing other intangible assets will be $50.6 million in fiscal 2016, $47.4 million in fiscal 2017, $45.5 million in fiscal 2018, $42.7 million in fiscal 2019 and $31.9 million in fiscal 2020.